L3mbtl2 - L3MBTL histone methyl-lysine binding protein 2 Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 300320
Summary
Predicted to enable methylated histone binding activity and promoter-specific chromatin binding activity. Predicted to be involved in negative regulation of transcription, DNA-templated. Predicted to act upstream of or within several processes, including ectoderm development; regulation of histone modification; and stem cell proliferation. Predicted to be active in nucleus. Orthologous to human L3MBTL2 (L3MBTL histone methyl-lysine binding protein 2). [provided by Alliance of Genome Resources, Apr 2022]
L3mbtl2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001033695.2 | NP_001028867.1 | lethal(3)malignant brain tumor-like protein 2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
lethal(3)malignant brain tumor-like protein 2 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS07485 | L3MBTL2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service